India to testify at USTR overcapacity probe on May 8

India is scheduled to present its case before the United States Trade Representative (USTR) at a public hearing on May 8, 2026, as part of a Section 301 inve...

What Happened

India is scheduled to present its case before the United States Trade Representative (USTR) at a public hearing on May 8, 2026, as part of a Section 301 investigation into structural manufacturing overcapacity across 16 economies and the European Union.
The US investigation, initiated in March 2026 by USTR Jamieson Greer, targets sectors including petrochemicals, steel, solar modules, textiles, health-related goods, construction materials, and automotive products.
India contests the US framing, arguing that any trade surpluses it runs are the result of macroeconomic factors rather than state-subsidised overcapacity or market-distorting industrial policies.
Indian trade officials and industry representatives will jointly present India's rebuttal at the hearing held at the US International Trade Commission in Washington.
The probe covers 16 economies (including China, India, South Korea, Vietnam, Indonesia, Taiwan, Malaysia, Cambodia, Thailand, Bangladesh, Japan, Mexico, Singapore, Switzerland, Norway) plus the EU.
If the USTR finds actionable practices, the US could impose additional tariffs, quantitative restrictions, or other trade barriers on the targeted sectors.

Static Topic Bridges

Section 301 of the Trade Act of 1974: Legal Framework

Section 301 of the US Trade Act of 1974 is the primary US statute authorising the President (delegated to the USTR) to investigate and respond to foreign trade practices deemed "unfair, unreasonable, or discriminatory" that burden or restrict US commerce.

The statute grants USTR authority to self-initiate investigations (as in the current case) or to act on petitions from US industry.
Key terminology: an act is "unjustifiable" if it violates international legal rights of the US (e.g., WTO commitments); "unreasonable" if inconsistent with norms even without a legal violation; "discriminatory" if it denies national treatment or MFN treatment.
Investigation timeline: generally 12 months from initiation to determination.
Remedies available: (a) additional import duties/tariffs; (b) withdrawal of trade agreement concessions; (c) binding agreement with the foreign government.
Section 301 was extensively used in the 1980s–1990s against Japan; its modern revival (first under the China investigation of 2018, then the current multi-country probe) marks a shift toward unilateral US trade enforcement.
WTO legality: the WTO Appellate Body ruled in 2000 that unilateral Section 301 actions violate WTO rules if imposed before exhausting WTO dispute settlement. The US has contested this, and the current US administration has not committed to WTO-first sequencing.

Connection to this news: India's testimony on May 8 is precisely the public hearing stage within the Section 301 investigation process — a statutory requirement that allows foreign governments and private parties to present evidence before the USTR makes its determination.

Manufacturing Overcapacity: Concept and India's Position

Industrial overcapacity refers to a situation where a country's installed production capacity in a sector significantly exceeds domestic demand, leading firms to dump surplus production in export markets at below-cost prices, often sustained by state subsidies or implicit government backing.

The US concern is that government-backed industrial policies in several economies — particularly featuring industrial subsidies, state-owned enterprise expansion, and suppressed domestic demand — have created global gluts in sectors like steel, solar, and petrochemicals.
India's steel capacity: approximately 180 million tonnes per annum (MTPA) installed; India is the world's second-largest steel producer after China; steel exports have grown significantly in recent years.
India's solar manufacturing capacity has expanded dramatically under the PLI (Production Linked Incentive) scheme for solar modules, with an installed module capacity projected at 60+ GW.
India's position: trade surpluses in specific sectors are driven by comparative advantage and competitive manufacturing, not state-subsidised dumping. India distinguishes its PLI-based incentives (which are WTO-notified and domestic demand-oriented) from China-style capacity overcreation.
The World Trade Organization's Agreement on Subsidies and Countervailing Measures (ASCM) governs actionable vs. non-actionable subsidies at the multilateral level.

Connection to this news: India's testimony is an articulation of this defence — arguing that its sectoral export performance reflects genuine competitiveness, not market-distorting overcapacity, and that the US should use WTO mechanisms rather than unilateral Section 301 action.

India's Production Linked Incentive (PLI) Scheme and Trade Policy Implications

The PLI scheme, launched in 2020-21, offers financial incentives to domestic and foreign manufacturers for incremental production above a defined baseline over a fixed period, across 14 priority sectors.

Sectors covered: mobile and electronic components, pharmaceuticals, medical devices, automobiles and auto components, advanced chemistry cell (ACC) batteries, telecom and networking products, textile products, food processing, solar PV modules, white goods (ACs and LEDs), specialty steel, and others.
Total PLI outlay: approximately ₹1.97 lakh crore across all 14 sectors.
PLI for solar modules: ₹4,500 crore outlay; targeted capacity addition of 10,000 MW high-efficiency solar modules.
The scheme is designed to increase domestic value addition, reduce import dependence, and make India a global manufacturing hub — goals aligned with the Atmanirbhar Bharat framework.
Trade tension: as PLI boosts Indian manufacturing output, exports in PLI sectors (solar, steel, pharma) have grown, potentially triggering trading partner concerns about unfair competition — precisely the US concern in the Section 301 probe.

Connection to this news: Solar modules and steel — two key PLI sectors — are explicitly listed in the USTR's overcapacity probe. India's testimony must therefore defend its PLI design as WTO-compatible and non-distorting.

WTO Dispute Settlement and the Limits of Multilateral Trade Law

The WTO Dispute Settlement Understanding (DSU) provides the multilateral mechanism for resolving trade disputes through Panels and the Appellate Body.

The WTO Agreement on Subsidies and Countervailing Measures (ASCM) prohibits certain subsidies (export subsidies, import substitution subsidies) and allows countervailing duties against actionable subsidies that cause material injury to a domestic industry.
India has faced numerous WTO disputes, including on solar panels (US-India Solar WTO case, where India's domestic content requirements were ruled WTO-inconsistent), export incentive schemes (MEIS ruled inconsistent in 2019), and sugar subsidies.
The US has paralysed the WTO Appellate Body since 2019 by blocking appointments, preferring bilateral/unilateral action. As of 2026, the Appellate Body remains non-functional.
India is a party to the Multi-Party Interim Appeal Arbitration Arrangement (MPIA) — a workaround for WTO appeals established by 26+ WTO members — but the US is not a party to it.
India's strategic choice: engage the US through the Section 301 hearing while simultaneously considering WTO consultations if tariff action is taken.

Connection to this news: India's May 8 testimony is a form of diplomatic engagement within a US domestic legal process. If the US imposes tariffs, India's recourse under WTO law is constrained by the Appellate Body crisis — making the hearing itself strategically critical.

Key Facts & Data

Section 301 of Trade Act of 1974: authorises USTR to investigate and act against unfair foreign trade practices; 12-month determination timeline.
Current Section 301 probe: covers 16 economies + EU; sectors include steel, solar, petrochemicals, textiles, health goods, construction materials, automotive.
India's steel capacity: approximately 180 MTPA; world's second-largest producer after China.
India's solar PLI: ₹4,500 crore outlay for 10,000 MW high-efficiency module manufacturing capacity.
WTO Appellate Body: non-functional since December 2019 due to US blocking of appointments.
MPIA (Multi-Party Interim Appeal Arbitration Arrangement): India is a party; the US is not.
WTO ASCM: governs actionable subsidies; allows countervailing duties against subsidies causing material injury.
US-India Solar WTO case ruling: India's domestic content requirements for solar cells ruled WTO-inconsistent.